Olaparib in the management of ovarian cancer

по Bixel, Kristin, Hays, John L
Опубликовано в: Pharmgenomics Pers Med (2015)

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies

по Reinbolt, Raquel E., Hays, John L.
Опубликовано 2013

Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series

по Bupathi, Manojkumar, Hays, John L., Chen, James L.
Опубликовано в: PLoS One (2017)

Proteomics and Ovarian Cancer: Integrating Proteomics Information Into Clinical Care

по Hays, John L., Kim, Geoffrey, Giuroiu, Iulia, Kohn, Elise C.
Опубликовано 2010

Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series

по ElNaggar, Adam C., Hays, John L., Chen, James L.
Опубликовано в: PLoS One (2016)

The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources

по Mathé, Ewy, Hays, John L., Stover, Daniel G., Chen, James L.
Опубликовано в: Yearb Med Inform (2018)

Biochemical Basis for the Functional Switch That Regulates Hepatocyte Growth Factor Receptor Tyrosine Kinase Activation

по Sheth, Payal R., Hays, John L., Elferink, Lisa A., Watowich, Stanley J.
Опубликовано 2008

Autophagy Induction Results in Enhanced Anoikis-resistance in Models of Peritoneal Disease

по Chen, James L, David, Jason, Cook-Spaeth, Douglas, Casey, Sydney, Cohen, David, Selvendiran, Karuppaiyah, Bekaii-Saab, Tanios, Hays, John L
Опубликовано в: Mol Cancer Res (2016)

Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways

по LaPak, Kyle M., Vroom, Dennis C., Garg, Ayush A., Guan, Xiangnan, Hays, John L., Song, Jonathan W., Burd, Christin E.
Опубликовано в: Oncotarget (2018)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

по Seligson, Nathan D., Stets, Colin W., Demoret, Bryce W., Awasthi, Achal, Grosenbacher, Nicholas, Shakya, Reena, Hays, John L., Chen, James L.
Опубликовано в: Oncotarget (2019)

Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma

по Sebastian, Nikhil T., Tan, Yubo, Miller, Eric D., Williams, Terence M., Noonan, Anne M., Hays, John L., Abdel-Misih, Sherif, Diaz, Dayssy Alexandra
Опубликовано в: JAMA Netw Open (2019)

A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety

по HAYS, JOHN L., KIM, GEOFF, WALKER, AMANDA, ANNUNZIATA, CHRISTINA M., LEE, JUNG-MIN, SQUIRES, JENNIFER, HOUSTON, NICOLE, STEINBERG, SETH M., KOHN, ELISE C.
Опубликовано 2013

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

по Seligson, Nathan D., Maradiaga, Richard D., Stets, Colin M., Katzenstein, Howard M., Millis, Sherri Z., Rogers, Alan, Hays, John L., Chen, James L.
Опубликовано в: NPJ Precis Oncol (2021)

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition

по Spaeth-Cook, Douglas, Burch, Mark, Belton, Robin, Demoret, Bryce, Grosenbacher, Nicholas, David, Jason, Stets, Colin, Cohen, David, Shakya, Reena, Hays, John L., Chen, James L.
Опубликовано в: Oncotarget (2018)

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma

по Seligson, Nathan D., Kautto, Esko A., Passen, Edward N., Stets, Colin, Toland, Amanda E., Millis, Sherri Z., Meyer, Christian F., Hays, John L., Chen, James L.
Опубликовано в: Oncologist (2018)

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma

по Seligson, Nathan D., Awasthi, Achal, Millis, Sherri Z., Turpin, Brian K., Meyer, Christian F., Grand'Maison, Anne, Liebner, David A., Hays, John L., Chen, James L.
Опубликовано в: JAMA Netw Open (2019)

Appendiceal Mixed Adeno-Neuroendocrine Carcinoma: A Population-Based Study of the Surveillance, Epidemiology, and End Results Registry

по Brathwaite, Shayna, Yearsley, Martha M., Bekaii-Saab, Tanios, Wei, Lai, Schmidt, Carl R., Dillhoff, Mary E., Frankel, Wendy L., Hays, John L., Wu, Christina, Abdel-Misih, Sherif
Опубликовано в: Front Oncol (2016)

FEASIBILITY AND SAFETY OF SEQUENTIAL RESEARCH-RELATED TUMOR CORE BIOPSIES IN CLINICAL TRIALS

по Lee, Jung-min, Hays, John L., Noonan, Anne M., Squires, Jennifer, Minasian, Lori, Annunziata, Christina, Wood, Bradford J., Yu, Minshu, Calvo, Katherine R., Houston, Nicole, Azad, Nilofer, Kohn, Elise C.
Опубликовано 2012

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk

по Lampert, Erika J., Hays, John L., Kohn, Elise C., Annunziata, Christina M., Minasian, Lori, Yu, Minshu, Gordon, Nicolas, Sissung, Tristan M., Chiou, Victoria L., Figg, William D., Houston, Nicole, Lee, Jung-Min
Опубликовано в: Oncotarget (2019)

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

по Lee, Jung-Min, Annunziata, Christina M., Hays, John L., Cao, Liang, Choyke, Peter, Yu, Minshu, An, Daniel, Turkbey, Ismail Baris, Minasian, Lori M., Steinberg, Seth M., Chen, Helen, Wright, John, Kohn, Elise C.
Опубликовано в: Gynecol Oncol (2020)